- Title
- 126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer
- Creators
- A.J. ArmstrongJ.R. GingrichM HäggmanW.M. StadlerJ.E. DamberL. BelkoffR. ClarkS. BrosmanO. NordleG. ForsbergM.A. CarducciR. Pili
- Publication Details
- European urology supplements : official journal of the European Association of Urology, v 11(1), pp e126-e126a
- Publisher
- Elsevier
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Surgery
- Other Identifier
- 991021916911604721
Abstract
126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer
European urology supplements : official journal of the European Association of Urology, v 11(1), pp e126-e126a
Feb 2012
Metrics
6 Record Views